Medicare Enrolled

Dr. Jesus Almendral, M.D.

Cardiovascular Disease · New Brunswick, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
10 PLUM ST, New Brunswick, NJ 08901
7322533340
In practice since 2008 (18 years)
NPI: 1346408689 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Almendral from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Almendral? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Almendral

Dr. Jesus Almendral is a cardiovascular disease specialist in New Brunswick, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Almendral performed 1,467 Medicare services across 422 unique beneficiaries.

Between the years covered by Open Payments, Dr. Almendral received a total of $5,996 from 28 pharmaceutical and/or device companies across 224 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Almendral is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 1,467 Medicare services $5,996 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,467
Medicare services
Bottom 24% in NJ for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
422
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~82 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
363 $100 $357
Evaluation of lower heart chamber assist device
Assessment of the function and status of a device that assists the lower chambers of the heart.
299 $34 $170
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
276 $121 $607
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
256 $81 $434
Evaluation of implantable heart and blood vessel monitoring system
This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity.
88 $18 $70
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
60 $110 $441
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
58 $67 $238
New patient office visit, complex (60-74 min) 24 $153 $742
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
18 $70 $318
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
14 $57 $228
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
11 $146 $606
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
0.0% medium
99.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,996
Total received (2018-2024)
Avg $857/year across 7 years
Top 32% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
224
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,574 (93.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$422 (7.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$960
2023
$841
2022
$705
2021
$867
2020
$392
2019
$674
2018
$1,557

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$269
Merck Sharp & Dohme LLC
$107
Alnylam Pharmaceuticals Inc.
$80
AstraZeneca Pharmaceuticals LP
$79
PFIZER INC.
$68
Daiichi Sankyo Inc.
$66
CVRx, Inc.
$51
Boston Scientific Corporation
$50
E.R. Squibb & Sons, L.L.C.
$45
Novartis Pharmaceuticals Corporation
$36
ABIOMED
$29
Lexicon Pharmaceuticals, Inc.
$23
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$21
SCPHARMACEUTICALS INC.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Top 3 companies account for 47.4% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$2,968
AstraZeneca Pharmaceuticals LP
$453
CVRx, Inc.
$310
Novartis Pharmaceuticals Corporation
$246
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$227
Akcea Therapeutics, Inc.
$213
ABIOMED
$200
PFIZER INC.
$170
Boston Scientific Corporation
$166
Merck Sharp & Dohme LLC
$161
Boehringer Ingelheim Pharmaceuticals, Inc.
$150
E.R. Squibb & Sons, L.L.C.
$150
Cardiovascular Systems Inc.
$98
Daiichi Sankyo Inc.
$98
Alnylam Pharmaceuticals Inc.
$80
Impulse Dynamics (USA) Inc.
$59
Merck Sharp & Dohme Corporation
$59
BOSTON SCIENTIFIC CORPORATION
$24
Lexicon Pharmaceuticals, Inc.
$23
Daxor Corporation
$22
SCPHARMACEUTICALS INC.
$20
IMPULSE DYNAMICS (USA) INC.
$17
Sobi, Inc
$16
Vifor Pharma, Inc.
$14
Acerta Pharma LLC
$14
Amgen Inc.
$13
Actelion Pharmaceuticals US, Inc.
$13
Bayer HealthCare Pharmaceuticals Inc.
$12
Top 3 companies account for 62.2% of all-time payments
Associated products mentioned in payments ›
AMPLATZER Occluders · AMVUTTRA · Adempas · Asahi Fielder coronary guide wire · BRILINTA · BVA-100 · Barostim Neo System · CAMZYOS · CARDIOMEMS · CardioMEMS HF System · CentriMag · ELIQUIS · ENTRESTO · FARXIGA · FASENRA · FUROSCIX · HeartMate · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · HeartMate Touch · INJECTAFER · Impella · Inpefa · JARDIANCE · LEQVIO · LOKELMA · LifeVest · OPTIMIZER · OPTIMIZER SMART SYSTEM · Optimizer · Optimizer Smart System · Peripheral Orbital Atherectomy System · RESONATE · RESONATE EL ICD VR · Repatha · TEGSEDI · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · UPTRAVI · VERQUVO · VIGILANT X4 CRT-D · VYNDAQEL · Veltassa · WAINUA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a cardiovascular disease specialist in New Brunswick?
Compare cardiologists in the New Brunswick area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists within 10 mi
486
Per 100K population
56.4
County median income
$109,028
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Almendral is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Almendral experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Almendral performed 363 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Almendral receive payments from pharmaceutical companies?
Yes. Dr. Almendral received a total of $5,996 from 28 companies across 224 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Almendral's costs compare to other cardiologists in New Brunswick?
Dr. Almendral's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Almendral) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →